The identification of autoantibodies, such as anti-aquaporin-4 (AQP4) antibody (3), and anti-myelin oligodendrocyte glycoprotein (MOG) antibody (4, 5), greatly aids in the differentiation of NMOSD from MS. This evidence concerns the gene AQP4 and myeloid sarcoma.